东南网首页| 繁体| 设为首页| 加入收藏
aa
您所在的位置:海外频道 >  今日世界 > 正文

Washington spends 250 mln USD on biowarfare activities in Ukraine: Russian Defense Ministry

2022-07-08 16:35 来源:Xinhua 责任编辑:孙紫腾

MOSCOW, July 8 (Xinhua) -- The United States has spent more than 250 million U.S. dollars on military biological activities in Ukraine since 2005, the Russian Defense Ministry said Thursday.

The ministry has been studying the work of U.S.-funded biological weapons programs in Ukraine and other regions, and has recently obtained a report on the activities of the Pentagon's Defense Threat Reduction Agency (DTRA) from 2005 to 2016, Igor Kirillov, chief of the Radiation, Chemical and Biological Defense Forces of the Russian Armed Forces, said during a briefing.

The report positively assessed the activities of the DTRA, namely the fact that the organization was able to transfer a national collection of microorganisms from Ukraine to the United States, conduct biological assessments, and implement projects aimed at studying particularly dangerous and economically significant infections that could worsen the epidemiological situation, Kirillov said.

The report also contained ambiguous data on the sponsors and executors of the Biological Threat Reduction Program in Ukraine. The activities of the sponsors of the program, such as the Soros Foundation, were not related to biosecurity issues.

"This confirms that the activities of the Pentagon in Ukraine are just a front for illegal military and biological research," Kirillov said.

Ukraine and other post-Soviet states have become "a testing ground" for biological weapons for the United States and its NATO allies, according to Kirillov. 

推荐阅读
东南网全球站点
FJSEN Global Sites
东南网美国站
东南网澳大利亚站
东南网香港站
东南网菲律宾站
东南网阿根廷站
东南网马来西亚站
东南网日本站
东南网新西兰站
东南网英国站
关注我们
Follow Us
联系我们
Contact Us
东南网海外频道联系电话、传真:0591-83729159
福建省福州市华林路84号福建日报大厦4楼
合作媒体
Associated Media
闽ICP备案号(闽ICP备05022042号)
网络出版服务许可证 (署)网出证(闽)字第018号
信息网络传播视听节目许可 许可证号:1310572
广播电视节目制作经营许可证(闽)字第085号
增值电信业务经营许可证 闽B2-20100029
福建日报报业集团拥有东南网采编人员所创作作品之版权,
未经报业集团书面授权,不得转载、摘编或以其他方式使用和传播